Product Details for: Arzerra
RETURN TO SEARCH RESULTS
PRODUCT LABEL
Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
Injection
Intravenous
100MG/5ML
Single-Dose Vial
351(a)
Arzerra
Disc
002
Injection
Intravenous
1,000MG/50ML
Single-Dose Vial
351(a)
Arzerra
Disc
003
Injection
Subcutaneous
20MG/0.4ML
Autoinjector
351(a)
Kesimpta
Rx
004
Injection
Subcutaneous
20MG/0.4ML
Pre-Filled Syringe
351(a)
Kesimpta
Disc
Proper Name
ofatumumab
ofatumumab
BLA Number
125326
125326
Applicant
Novartis Pharmaceuticals Corporation
Novartis Pharmaceuticals Corporation
Original Approval Date
October 26, 2009
October 26, 2009
Date of First Licensure